Immunochemical detection of arylamine N-acetyltransferase in normal and neoplastic bladder

Journal of Histochemistry and Cytochemistry

Volumn 44, Issue 9, 1996, Pages 1059-1067

  Stanley, Lesley A ^a   Coroneos, Erifili ^a   Cuff, Rebecca ^a   Hickman, Dean ^a   Ward, Alison ^a   Sim, Edith ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Antipeptide; Bladder; Cancer; Human; Immunoblotting; Immunohisto chemistry; N Acetyltransferase

Indexed keywords

AROMATIC AMINE; ARYLAMINE ACETYLTRANSFERASE;

ARTICLE; BLADDER CANCER; BLADDER EPITHELIUM; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; ENZYMURIA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; OCCUPATIONAL CANCER; PRIORITY JOURNAL; XENOBIOTIC METABOLISM;

RUBIA TINCTORUM; SUS SCROFA;

EID: 0029812630     PISSN: 00221554     EISSN: None     Source Type: Journal    
DOI: 10.1177/44.9.8773572     Document Type: Article

References (62)

1. Bi W, Jian YR, Hemstreet GP, Fang P, Asal NR, Zang M, Min KW, Ma Z, Lee E, Li G, Hurst RE, Bonner RB, Wang Y, Fradet Y, Yin S (1993) Field molecular epidemiology: feasibility of monitoring for the malignant bladder cell phenotype in a benzidine-exposed occupational cohort. J Occup Med 35:20-27
2. Blum M, Demierre A, Grant DM, Heim M, Meyer DA (1991) Molecular mechanism of slow acetylation of drugs and carcinogens in humans. Proc Natl Acad Sci USA 88:5237-5241
3. Blum M, Grant DM, McBride W, Heim M, Meyer UA (1990) Human arylamine N-acetyltransferase genes: isolation, chromosomal localization, and functional expression. DNA Cell Biol 9:193-201
4. Cartwright RA, Glashan RW, Rogers HJ, Ahmad RA, Barham-Hall D, Higgins E, Kahn MA (1982) Role of N-acetyltransferase phenotypes in bladder carcinogenesis: a pharmacogenetic epidemiological approach to bladder cancer. Lancet 2:842-846
5. Coroneos E, Gordon JW, Kelly SL, Wang PD, Sim E (1991) Drug metabolizing N-acetyltransferase activity in human cell lines. Biochim Biophys Acta 1073:593-599
6. Coroneos E, Sim E (1991) N-acetyltransferase in human urothelium and bladder cell lines. Biochem Soc Trans 19:129s
7. Cuff R, Davies J, Sim E, Smelt V, Stanley L (1996) Expression of N-acetyltransferase Type I (NAT1) in a subpopulation of exfoliated cells from human urine. Hum Exp Toxicol 15:149
8. Cunningham C, Dunlop MG, Wyllie AH, Bird CC (1993) Deletion mapping in colorectal cancer of a putative tumour suppressor gene in 8p22-p21.3. Oncogene 8:1391-1396
9. Deguchi T (1992) Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem 267:18140-18147
10. Dewan A, Jani JP, Shah KS, Kashyap SK (1986) Urinary excretion of benzidine in relation to the acetylator status of occupationally exposed subjects. Hum Toxicol 5:95-97
11. Ebisawa T, Deguchi T (1991) Structure and restriction fragment length polymorphism of genes for human liver arylamine N-acetyltransferases. Biochem Biophys Res Commun 177:1252-1257
12. Edwards RJ, Singleton AM, Murray BP, Davies DS, Boobis AR (1995) Short synthetic peptides exploited for reliable and specific targeting of antibodies to the C-termini of cytochrome P450 enzymes. Biochem Pharmacol 49:39-47
13. Edwards RJ, Singleton AM, Sesardic D, Boobis AR, Davies DS (1988) Antibodies to a synthetic peptide that react specifically with a common surface region on two hydrocarbon-inducible isoenzymes of cytochrome P-450 in the rat. Biochem Pharmacol 37:3735-3741
14. Emi M, Fujiwara Y, Nakajima T, Tsuchiya E, Tsuda H, Hirohashi S, Maeda Y, Tsuruta K, Miyaki M, Nakamura Y (1992) Frequent loss of heterozygosity for loci on chromosome 8p in hepatocellular carcinoma, colorectal cancer, and lung cancer. Cancer Res 52:5368-5372
15. Evans DAP, Manley KA, McKusick VA (1960) Genetic control of isoniazid metabolism in man. Br Med J 2:485-491
16. Frederickson SM, Hatcher JF, Reznikoff CA, Swaminathan S (1992) Acetyl transferase-mediated metabolic activation of N-hydroxy-4-aminobiphenyl by human uroepithelial cells. Carcinogenesis 13:955-961
17. Frederickson SM, Messing EM, Reznikoff CA, Swaminathan S (1994) Relationship between in vivo acetylator phenotypes and cytosolic N-acetyltransferase and O-acetyltransferase activities in human uroepithelial cells. Cancer Epidemiol Biomarkers Prevent 3:25-32
18. Grant DM (1993) Molecular genetics of the N-acetyltransferases. Pharmacogenetics 3:45-50
19. Grant DM, Blum M, Beer M, Meyer UA (1991) Monomorphic and polymorphic human arylamine N-acetyltransferases: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39:184-191
20. Grant DM, Blum M, Meyer UA (1992) Polymorphisms of N-acetyltransferase genes. Xenobiotica 22:1073-1081
21. Grant DM, Lottspeich F, Meyer UA (1989) Evidence for two closely related isozymes of arylamine N-acetyltransferase in human liver. FEBS Lett 244:203-207
22. Grant DM, Morike K, Eichelbaum M, Meyer UA (1990) Acetylation pharmacogenetics. The slow acetylator phenotype is caused by decreased or absent arylamine N-acetyltransferase in human liver. J Clin Invest 85:968-972
23. Gunawardhana L, Barr J, Weir AJ, Brendel K, Sipes IG (1991) The N-acetylation of sulfamechazine and p-aminobenzoic acid by human liver slices in dynamic organ culture. Drug Metab Disp 19:648-654
24. Hanke J, Krajewska B (1990) Acetylation phenotypes and bladder cancer. J Occup Med 32:917-918
25. Hein DW, Doll MA, Rustan TD, Gray K, Feng Y, Ferguson RJ, Grant DM (1993) Metabolic activation and deactivation of arylamine carcinogens by recombinant human NAT1 and polymorphic NAT2 acetyltransferases. Carcinogenesis 14:1633-1638
26. Hein DW, Ferguson RJ, Doll MA, Rustan TD, Gray K (1994) Molecular genetics of human polymorphic N-acetyltransferase: enzymatic analysis of 15 recombinant wild-type, mutant, and chimeric NAT2 allozymes. Hum Mol Genet 3:729-734
27. Henderson CJ, Wolf CR (1992) Immunodetection of proteins by Western blotting. In Manson MM, ed. Immunochemical Protocols. Totowa, NJ, Humana Press, 221-233
28. Hickman D (1992) Genotyping human polymorphic arylamine N-acetyltransferase: identification of new slow allotypic variants. Pharmacogenetics 2:217-226
29. Hickman D, Palamanda J, Unadkat JD, Sim E (1995) Enzyme kinetic properties of human recombinant arylamine N-acetyltransferase 2 allotypic variants expressed in E. coli. Biochem Pharmacol 50:697-703
30. Hickman D, Risch A, Buckle V, Spurr NK, Jeremiah SJ, McCarthy A, Sim E (1994) Chromosomal localization of human genes for arylamine N-acetyliransferase. Biochem J 297:441-445
31. Hickman D, Sim E (1991) N-Acetyltransferase polymorphism. Comparison of phenotype and genotype in humans. Biochem Pharmacol 42:1007-1014
32. Hirvonen A, Nylund L, Kociba P, Husgafvel-Pursiainen K, Vainio H (1994) Modulation of urinary mutagenicity by genetically determined carcinogen metabolism in smokers. Carcinogenesis 15:813-815
33. Kadlubar F (1991) Carcinogenic aromatic amine metabolism and DNA adduct detection in humans. In Ernster L, ed. Xenobiotics and Cancer. London, Taylor and Francis, 329-338
34. Kadlubar FF (1994) Biochemical individuality and its implications for drug and carcinogen metabolism: recent insights from acetyltransferase and cytochrome P4501A2 phenotyping and genotyping in humans Drug Metab Rev 26:37-46
35. Kadlubar FF, Butler MA, Kaderlik KR, Chou HC, Lang NP (1992) Polymorphisms for aromatic amine metabolism in humans: relevance for human carcinogenesis. Environ Health Persp 98:69-74
36. Kadlubar FF, Unruh LE, Flammang TJ, Sparks D, Mitchum RK, Mulder GJ (1981) Alteration of urinary levels of the carcinogen, N-hydroxy-2-naphthylamine, and its N-glucuronide in the rat by control of urinary pH, inhibition of metabolic sulfation, and changes in biliary excretion. Chem Biol Interact 33:129-147
37. Kelly SL, Sim E (1991) Expression of N-acetyl transferase in a human monocytic cell-line, U937. Hum Exp Toxicol 10:33-38
38. Kirlin WG, Trinidad A, Yerokun T, Ogolla F, Ferguson RJ, Andrews AF, Brady PK, Hein DW (1989) Polymorphic expression of acetyl coenzyme A-dependent arylamine N-acetyltransferase and acetyl coenzyme A-dependent O-acetyltransferase-mediated activation of N-hydroxyarylamines by human bladder cytosol. Cancer Res 49:2448-2454
39. Kloth MT, Gee RL, Messing EM, Swaminathan S (1994) Expression of N-acetyltransferase (NAT) in cultured human. Carcinogenesis 15:2781-2787
40. Knowles MA, Shaw ME, Proctor AJ (1993) Deletion mapping of chromosome 8 in cancers of the urinary bladder using restriction fragment length polymorphisms and microsatellite polymorphisms. Oncogene 8:1357-1364
41. Land SJ, Zukowski K, Lee MS, Debiec Rychter M, King CM, Wang CY (1989) Metabolism of aromatic amines: relationships of N-acetylation, O-acetylation, N,O-acetyltransfer and deacetylation in human liver and urinary bladder. Carcinogenesis 10:727-731
42. Lin JH, Zhao H, Sun TT (1995) A tissue-specific promoter that can drive a foreign gene to express in the suprabasal urothelial cells of transgenic mice. Proc Natl Acad Sci USA 92:679-683
43. Lower GM (1982) Concepts in causality: chemically induced human urinary bladder cancer. Cancer 49:1056-1066
44. Matas N, Thygesen P, Sim E (1995) Molecular genetics of human arylamine N-acetyltransferase: physical mapping. Br J Clin Pharmacol 40:522P
45. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi B, Ilett KF, Kadlubar FF (1992) N- and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferases expressed in COS-1 cells. Biochem Biophys Res Commun 185:839-844
46. Nguyen G-K, Kline TS (1992) Essentials of Exfoliative Cytology. New York, Tokyo, Igaku-Shoin
47. Ohsako S, Deguchi T (1990) Cloning and expression of cDNAs for polymorphic and monomorphic arylamine N-acetyltransferases from human liver. J Biol Chem 265:4630-4634
48. Risch A, Wallace DMA, Bathers S, Sim E (1995) Slow N-acetylation genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4:231-236
49. Sagerman PM, Saigo PE, Sheinfeld J, Charitonowics E, Cordon-Cardo C (1994) Enhanced detection of bladder cancer in urine cytology with Lewis X, M344 and 19A211 antigens. Acta Cytol 38:517-523
50. Sim E, Hickman D, Coroneos E, Kelly SL (1992) Arylamine N-acetyltransferase. Biochem Soc Trans 20:304-309
51. Sinues B, Perez J, Bernal ML, Saenz MA, Lanuza J, Bartolome M (1992) Urinary mutagenicity and N-acetylation phenotype in textile industry workers exposed to arylamines. Cancer Res 52:4885-4889
52. Smith G, Stanley LA, Sim E, Strange R, Wolf CR (1995) Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25:27-63
53. Spurr N (1995) Report of the Second International Workshop on Human Chromosome 8 Mapping 1994. Cytogenet Cell Genet 68:147-164
54. Swaminathan S, Hatcher JF (1992) Comparison of acryltransferase-mediated mutagenicity and nucleic acid binding of N-acetoxy-4-acetylaminobiphenyl by hepatic and bladder microsomes from rats and dogs. Environ Mol Mutagenesis 20:61-72
55. Swaminathan S, Reznikoff CA (1992) Metabolism and nucleic acid binding of N-hydroxy-4-acetylaminobiphenyl and N-acetoxy-4-acetylaminobiphenyl by cultured human uroepithelial cells. Cancer Res 52:3286-3294
56. Tanaka K, Takashi M, Miyake K, Koshikawa T (1994) Immunocytochemically demonstrated expression of epithelial membrane antigen and carcinoembryonic antigen by exfoliated urinary cells in patients with bladder cancer. Urol Int 52:140-144
57. Vatsis KP, Weber WW, Bell DA, Dupret JM, Evans DAP, Grant DM, Hein DW, Lin HJ, Meyer UA, Relling MV, Sim E, Suzuki T, Yamazoe Y (1995) Nomenclature for N-acetyltransferases. Pharmacogenetics 5:1-17
58. Vineis P, Bartsch H, Caporaso N, Harrington AM, Kadlubar FF, Landi MT, Malaveille C, Shields PG, Skipper P, Talaska G, Tannenbaum SR (1994) Genetically based N-acetyltransferase metabolic polymorphism and low-level environmental exposure to carcinogenesis. Nature 369:154-156
59. Ward A, Hickman D, Gordon JW, Sim E (1992) Arylamine N-acetyltransferase in human red blood cells. Biochem Pharmacol 44:1099-1104
60. Ward A, Summers MJ, Sim E (1995) Purification of recombinant human N-acetyltransferase type 1 (NAT1) expressed in E. coli and characterization of its potential role in folate metabolism. Biochem Pharmacol 49:1759-1767
61. Wu XR, Lin JH, Walz T, Haner M, Yu J, Aebi U, Sun TT (1994) Mammalian uroplakins. A group of highly conserved urothelial differentiation-related membrane proteins. J Biol Chem 269:13716-13724
62. Yu J, Lin JH, Wu XR, Sun TT (1994) Uroplakins Ia and Ib, two major differentiation products of bladder epithelium, belong to a family of four transmembrane domain (4TM) proteins. J Cell Biol 125:171-182